Drug or treatment

Povorcitinib clinical trials

• 2Clinical trials
• 20Countries

All recruiting trials (2)

• Povorcitinib for adolescents with moderate to severe hidradenitis suppurativa

  This trial tests the oral drug povorcitinib in adolescents aged 12–17 with moderate to severe hidradenitis suppurativa to see if it is safe, how the body handles it, and whether it reduces lesions over a 54-week treatment period.

  Recruiting at 28 sites Phase 2 Incyte Corporation · Birmingham, Alabama and 29 other locations · NCT07213973

• Continuation of treatment with povorcitinib for previous trial participants

  This study lets people who have already benefited from the medication povorcitinib in a previous trial keep using it to see if it continues to help with their Hidradenitis Suppurativa.

  Recruiting at 247 sites Phase 3 Incyte Corporation · Birmingham, Alabama and 305 other locations · NCT06855498

Quick answers

How many clinical trials of Povorcitinib are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 20 countries. The most sites are in Canada (2 trials), United States (2 trials), Argentina (1 trial), Australia (1 trial), Austria (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →